Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4072387 | Journal of Orthopaedic Science | 2011 | 5 Pages |
Abstract
The treatment of rheumatoid arthritis (RA) has recently seen a paradigm shift with the introduction of biological therapy, but there is concern that this will result in an increased incidence of infection. Postoperative infection is always a potentially problematic complication, even though a large review by the British Society for Rheumatology has shown that anti-tumor necrosis factor (TNF) therapy is not associated with an increased risk of overall serious infection in comparison with disease-modifying antirheumatic drugs [1]. It is well known that Staphylococcus aureus and Staphylococcus epidermidis are common pathogens of postoperative infection, although Salmonella infection after joint replacement is quite rare in the English literature [2-19], accounting for <0.3% of cases of septic arthritis [20]. Furthermore, there have been no reports of Salmonella infection following etanercept and few reports discussing the source of Salmonella infection.
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Kenichi Oe, Takahiko Wada, Hiroshi Ohno, Taketoshi Kushida, Hirokazu Iida,